Patents by Inventor Chiara Brambati

Chiara Brambati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210340636
    Abstract: The present invention is directed to methods for assaying for the presence of SARS-CoV-2 in a sample, including a clinical sample, and to oligonucleotides, reagents, and kits useful in such assays. In particular, the present invention is directed to such assays that are rapid, accurate and specific for the detection of SARS-CoV-2.
    Type: Application
    Filed: July 13, 2021
    Publication date: November 4, 2021
    Applicant: DiaSorin S.p.A.
    Inventors: Chiara Brambati, Simone Bocchetta, Giulia Minnucci
  • Publication number: 20210324484
    Abstract: The present invention is directed to methods for assaying for the presence of SARS-CoV-2 in a sample, including a clinical sample, and to oligonucleotides, reagents, and kits useful in such assays. In particular, the present invention is directed to such assays that are rapid, accurate and specific for the detection of SARS-CoV-2.
    Type: Application
    Filed: October 23, 2020
    Publication date: October 21, 2021
    Applicant: DiaSorin S.p.A.
    Inventors: Chiara Brambati, Simone Bocchetta, Giulia Minnucci
  • Patent number: 11149320
    Abstract: The present invention is directed to methods for assaying for the presence of SARS-CoV-2 in a sample, including a clinical sample, and to oligonucleotides, reagents, and kits useful in such assays. In particular, the present invention is directed to such assays that are rapid, accurate and specific for the detection of SARS-CoV-2.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: October 19, 2021
    Assignee: DiaSorin S.p.A.
    Inventors: Chiara Brambati, Simone Bocchetta, Giulia Minnucci
  • Patent number: 10815539
    Abstract: The present invention is directed to methods for assaying for the presence of SARS-CoV-2 in a sample, including a clinical sample, and to oligonucleotides, reagents and kits useful in such assays. In particular, the present invention is directed to such assays that are rapid, accurate and specific for the detection of SARS-CoV-2.
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: October 27, 2020
    Assignee: DiaSorin S.p.A.
    Inventors: Chiara Brambati, Simone Bocchetta, Giulia Minnucci